From: MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2
Patient characteristics
Cases (n = 20)
Sex
Male
13
Female
7
Age
< 65
12
≥ 65
8
Tumor size (cm)
< 4
14
≥ 4
6
Histological grade
G1
11
G2 + G3
9
TNM stage
I/II
16
III/IV
4